The single nucleoside transport function of mouse S49 lymphoblasts also transports purine bases (B. Aronow and B. Ullman, J. Biol. Chem. 261:2014Chem. 261: -2019Chem. 261: , 1986). This transport of purine bases by S49 cells is sensitive to inhibition by dipyridamole (DPA) and 4-nitrobenzylthioinosine, two potent inhibitors of nucleoside transport. Therefore, wild-type S49 cells cannot salvage low hypoxanthine concentrations in the presence of 10 ,uM DPA and 11 ,uM azaserine; the latter is a potent inhibitor of purine biosynthesis. Among a mutagenized wild-type population, a cell line, JPA2, was isolated which could proliferate in 50 ,M hypoxanthine-11 ,uM azaserine-10 M DPA. The basis for the survival of JPA2 cells under these selective conditions was expression of a unique, high-affinity purine nucleobase transport function not present in wild-type cells. JPA2 cells could transport 5 ,uM concentrations of hypoxanthine, guanine, and adenine 15-to 30-fold more efficiently than parental cells did. Kinetic analyses revealed that the affinity of the JPA2 transporter for all three purine bases was much greater than that of the wild-type nucleobase transport system. Moreover, nucleobase transport in JPA2 cells, unlike that in parental cells, was insensitive to inhibition by DPA, 4-nitrobenzylthioinosine, sulfhydryl reagents, and nucleosides. No alterations in nucleoside transport capability, phosphoribosylpyrophosphate levels, or purine phosphoribosyltransferase enzymes were detected in JPA2 cells. Thus, JPA2 cells express a novel nucleobase transport capability which can be distinguished from the nucleoside transport function by multiple biochemical parameters.
The single nucleoside transport function of mouse S49 lymphoblasts also transports purine bases (B. Aronow and B. Ullman, J. Biol. Chem. 261:2014 Chem. 261: -2019 Chem. 261: , 1986 ). This transport of purine bases by S49 cells is sensitive to inhibition by dipyridamole (DPA) and 4-nitrobenzylthioinosine, two potent inhibitors of nucleoside transport. Therefore, wild-type S49 cells cannot salvage low hypoxanthine concentrations in the presence of 10 ,uM DPA and 11 ,uM azaserine; the latter is a potent inhibitor of purine biosynthesis. Among a mutagenized wild-type population, a cell line, JPA2, was isolated which could proliferate in 50 ,M hypoxanthine-11 ,uM azaserine-10 M DPA. The basis for the survival of JPA2 cells under these selective conditions was expression of a unique, high-affinity purine nucleobase transport function not present in wild-type cells. JPA2 cells could transport 5 ,uM concentrations of hypoxanthine, guanine, and adenine 15-to 30-fold more efficiently than parental cells did. Kinetic analyses revealed that the affinity of the JPA2 transporter for all three purine bases was much greater than that of the wild-type nucleobase transport system. Moreover, nucleobase transport in JPA2 cells, unlike that in parental cells, was insensitive to inhibition by DPA, 4-nitrobenzylthioinosine, sulfhydryl reagents, and nucleosides. No alterations in nucleoside transport capability, phosphoribosylpyrophosphate levels, or purine phosphoribosyltransferase enzymes were detected in JPA2 cells. Thus, JPA2 cells express a novel nucleobase transport capability which can be distinguished from the nucleoside transport function by multiple biochemical parameters.
The entry of purine bases into mammalian cells has been reported to occur by a facilitated diffusion mechanism (5, 17) , although the multiplicity and substrate specificities of the base transporters are not well defined. Kinetic data suggest the existence of multiple classes of nucleobase transporters within the animal kingdom. (i) The kinetic parameters for hypoxanthine and adenine permeation vary widely among cultured mammalian cell lines (1, 8, 13, 19, 22, 28, 29) . (ii) Most (13, 17, 22, 28) but not all (4a, 8, 20 ) studies on purine nucleobase transport support the existence of distinct permeases for hypoxanthine and adenine in animal cells. (iii) Reciprocal inhibition of transport by nucleobases and nucleosides can be demonstrated in some animal cells (4a, 13, 18, 19, 22, 23, 29) but not in other cell lines (8, (18) (19) (20) , suggesting a role of the nucleoside transport system in nucleobase transport. In mouse S49 lymphoblasts, Aronow and Ullman (4a) have demonstrated genetically that the single nucleoside transport function cotransports purine nucleobases. S49 cells genetically deficient in nucleoside transport are also markedly deficient in their capacity to transport hypoxanthine, adenine, and guanine. Moreover, two potent inhibitors of nucleoside transport (15, 16, 21) , dipyridamole (DPA) and 4-nitrobenzylthioinosine (NBMPR), can pharmacologically simulate the genetic deficiency in nucleobase transport (4a) .
To analyze and characterize mammalian nucleobase transporters further, we used biochemical genetic approaches to generate variant S49 cells which efficiently salvage hypoxanthine in the presence of azaserine, an inhibitor of purine biosynthesis (14) , and DPA. These mutant cells express a novel, high-affinity transport system for hypoxanthine, adenine, and guanine which possesses biochemical properties [3H]guanine (11 Ci/mmol) was prepared from [3H]guanosine (11 Ci/mmol) by phosphorolysis with purine nucleoside phosphorylase from Sigma Chemical Co. N-Methyl-N-nitro-N'-nitrosoguanidine (MNNG) was provided by K & K Laboratories, Inc. of ICN Pharmaceuticals Inc. Erythro-9-(2-hydroxy-3-nonyl)-adenine was bought from BurroughsWellcome Co. NBMPR, DPA, azaserine, and nonradioactive nucleobases, nucleosides, and nucleotides were obtained from Sigma. All other materials, chemicals, and reagents were of the highest purity commercially available.
Cell culture conditions. The S49 cell line is a T-cell lymphoma originally derived from a BALB/c mouse by Horibata and Harris (10) . Culture conditions for S49 cells have been described previously (25) .
Isolation of the JPA2 clone. The conditions for the mutagenesis of S49 cells with MNNG have been described elsewhere (2, 26, 27) . The JPA2 cell line was isolated by plating mutagenized wild-type cells over mouse embryo fibroblast feeder layers (7) in semisolid (0.3%) agarose containing 50 ,uM hypoxanthine, 11 ,uM azaserine, and 10 puM Growth rate determinations. The abilities of wild-type and mutant S49 cells to salvage hypoxanthine in the absence or presence of inhibitors of nucleoside transport were ascertained as described by Aronow and Ullman (4a). Hypoxanthine salvage was determined in the presence of azaserine, an inhibitor of the purine-biosynthetic enzyme phosphoribosylformylglycineamide synthetase (14) . The growth sensitivities of wild-type and JPA2 cells to nucleosides were compared as described previously (2, 26, 27 Enzyme assays. Cell-free extracts were prepared and gel sieved over Sephadex G25, and hypoxanthine-guanine phosphoribosyltransferase and adenine phosphoribosyltransferase activities were measured as described by lovannisci et al. (11) .
Measurement of phosphoribosylpyrophosphate levels. Phosphoribosylpyrophosphate levels were determined by previously described modifications (20) of method I of Kornberg et al. (12) .
Mutation frequencies. The ability of MNNG to induce the JPA2 transport phenotype was determined as follows. Samples (25 ml) of wild-type cells at a density of 106 cells per ml were incubated for 3 h with 0, 2, 4, 6, or 8 ,ug of MNNG per ml as described above for the selection of JPA2 cells. Cells were separated from MNNG, grown for 7 to 10 generations, and plated selectively in 50 ,uM hypoxanthine-11 ,uM azaserine-10 FM DPA. As controls, cells were also plated in either 0.3 mM ouabain or 50 ,uM 6-thioguanine, two other cytotoxic agents, which select for mutations independent of those affecting nucleoside or nucleobase transport. Colonies were detected visually, and several of each type were picked and tested for the appropriate growth phenotype.
RESULTS
Growth phenotype of the JPA2 clone. The nucleoside transport function of S49 cells also mediates the translocation of purine bases (4a). This transport of nucleobases by wild-type S49 cells is inhibited by DPA and NBMPR (4a). Either 10 ,uM DPA or 10 p.M NBMPR could prevent the growth of wild-type cells in the presence of low concentrations of hypoxanthine in the presence of azaserine (Fig. 1) . Thus, a selective strategy was devised in which cells capable of salvaging hypoxanthine in the presence of DPA could be isolated. JPA2 cells were isolated by virtue of their ability to salvage 50 ,uM hypoxanthine in the presence of 11 FM azaserine-10 ,uM DPA. A comparison of the abilities of wild-type and JPA2 cells to grow in increasing hypoxanthine concentrations in the presence of azaserine is depicted in Fig. 1 . Unlike wild-type cells, JPA2 cells could salvage low hypoxanthine concentrations in the presence of either 10 ,uM DPA or 10 ,uM NBMPR, concentrations which abrogate nucleoside transport in wild-type S49 cells (2, 3, 6) .
Both NBMPR and DPA are also capable of protecting wild-type S49 cells from the cytotoxic effects of any of a spectrum of nucleosides (2) (3) (4) 6 nucleoside transport affected the concentrations of hypoxanthine required to overcome azaserine toxicity in JPA2 cells, the effects of DPA and NBMPR on nucleoside toxicity in wild-type and mutant cells were compared. Figure 2 demonstrates the effects of 10 ,uM DPA and 10 ,uM NBMPR on the toxicity of 5-fluorouridine in wild-type and mutant cells. Both cell lines were equally sensitive to 5-fluorouridine toxicity, and 10 p.M DPA and 10 ,uM NBMPR were equally effective in ameliorating the toxicity of the pyrimidine nucleoside analog toward both cell types (Fig. 2) . Similar results were obtained with other nucleosides, such as adenosine and deoxyguanosine (data not shown).
Transport measurements. The ability of JPA2 cells to salvage hypoxanthine in the presence of DPA or NBMPR without apparently altering the inhibitory action of DPA and NBMPR on nucleoside toxicity suggested that the JPA2 cells might be altered in their ability to transport hypoxanthine. Therefore, the abilities of wild-type and JPA2 cells to transport 5 ,uM [3H]hypoxanthine were compared (Fig. 3) . Hypoxanthine (5 ,uM) was transported 15-to 25-fold more rapidly by JPA2 cells than by wild-type cells. In contrast to wild-type cells, hypoxanthine transport by JPA2 cells was largely refractory to inhibition by either 10 ,uM DPA or 10 ,uM NBMPR (Fig. 3) . To examine whether the transport velocities of other nucleobases were augmented in JPA2 cells, the abilities of wild-type and mutant cells to transport 5 ,uM [3H]adenine or 5 ,uM [3H]guanine were also measured. Clearly, the rates at which JPA2 cells could transport all three nucleobases were elevated considerably over those found for wild-type cells (Fig. 4) . The transport of both adenine and guanine by JPA2 cells, unlike that by wild-type cells, was also unaffected by 10 ,uM DPA or 10 ,uM NBMPR (data not shown). The rates of influx of [3H]uracil, a pyrimidine base, were similar in wild-type and JPA2 cells (data not shown).
The kinetic parameters for hypoxanthine and adenine transport by JPA2 cells were determined (Fig. 5) To characterize the JPA2 transporter further, the ability of nucleobases and nucleosides to compete for the transport of [3H]hypoxanthine into JPA2 cells was examined. As expected, low concentrations of adenine and guanine prevented the influx of [3H]hypoxanthine, whereas pyrimidine bases, such as uracil, and adenosine had no effect (Fig. 6) . Furthermore, sulfhydryl reagents such as p-chloromercuribenzoate and N-ethylmaleimide, which markedly inhibit nucleoside transport in wild-type S49 cells (19) , did not interfere with the translocation of hypoxanthine by JPA2 cells (Fig. 6) . Adenine transport by JPA2 cells was inhibited 50% by excess hypoxanthine but unaffected by adenosine (Fig. 6 ). Residual adenine transport in the presence of 1 mM hypoxanthine by JPA2 cells is mediated by a combination of the nucleoside transport function and a passive diffusion component (4a).
To ascertain whether JPA2 cells were altered in their nucleoside transport capability, the transport of 5 Table 2 . The data in Table 2 indicate that the JPA2 mutation was not obtained without mutagenesis. However, the optimal concentration of MNNG for induction of the JPA2 transport phenotype was different from that concentration which resulted in the highest frequency of clones resistant to either 0.3 mM ouabain or 50 ,uM 6-thioguanine (Table 2) . DISCUSSION JPA2 cells stably express a unique, high-affinity purine base transport function with properties distinct from previously described mammalian nucleobase permeases. Cells which express the JPA2 nucleobase transport system could be selected among wild-type S49 cells, since the S49 nucleoside transport function cotransports purine bases and is amenable to pharmacologic inhibition by DPA (4a). Aronow and Ullman (4a) have demonstrated that either a genetic or pharmacologic deficiency in nucleoside transport prevents S49 cells from adequately salvaging low concentrations of hypoxanthine in the presence of azaserine. JPA2 cells were capable of surviving in the selective medium by virtue of their expression of the DPA-insensitive, high-affinity hypoxanthine carrier system. This base transporter was also insensitive to NBMPR and sulfhydryl reagents. Among purines and pyrimidines, the JPA2 carrier appeared to be specific for purine bases. Nucleoside transport by JPA2 cells was similar to that found in wild-type cells and remained sensitive to DPA as well as to NBMPR, and pyrimidine bases were not transported and did not inhibit purine base transport into JPA2 cells.
The kinetic and biochemical parameters of the JPA2 nucleobase carrier system differentiate it from previously described mammalian purine base transporters. In many mammalian cells, hypoxanthine and nucleosides each interfere with the translocation of the other, indicating a role of the nucleoside transport system in base permeation (4a, 13, 18, 19, 22, 23, 29) . This group of cells includes Novikoff hepatoma cells, HTC rat hepatoma cells, Chinese hamster ovary cells, Ehrlich ascites cells, and Chinese lung fibroblasts, as well as parental wild-type S49 cells. In those cells which appear to possess a common nucleoside-hypoxanthine transport system, hypoxanthine transport is DPA sensitive but NBMPR insensitive (18, 19) . Among the latter, only Novikoff hepatoma cells have a Km value for hypoxanthine transport below 2 mM (19) . Conversely, Plagemann The substrate specificity of nucleobase transporters appears to vary among mammalian cells. Based on lack of competition for transport, distinct carriers for hypoxanthine and adenine have been reported for Novikoff hepatoma (13) and Chinese hamster ovary cells (28) . Adenine influx was inhibited by hypoxanthine in L1210 cells, supporting the existence of a common carrier (8) . Adenine transport is also inhibited by nucleosides in Chinese hamster lung fibroblasts (22) but not in L1210 cells (8) . The apparent Km values for the transport of adenine were approximately 2 to 3 mM in rat hepatoma, mouse L1210, and Chinese hamster ovary cells (13, 17, 24) . Aronow and Ullman (4a) have demonstrated genetically and pharmacologically that the nucleoside transport function of wild-type S49 cells can transport adenine and hypoxanthine, as well as guanine. This transport of all three purine bases is diminished by a genetic or pharmacologically elicited deficiency in nucleoside transport in S49 cells. Thus, both the wild-type nucleoside-nucleobase carrier and the JPA2 base transporter can recognize and The genetic basis for the expression of the nucleobase carrier of JPA2 cells is not currently known. First, it is possible that the nucleoside transport function of wild-type cells has been altered. Although this hypothesis cannot be eliminated, the nucleoside transport system of JPA2 cells appears indistinguishable from the parental nucleoside transporter. Since virtually every biochemical parameter of nucleobase transport in JPA2 cells distinguishes it from wild-type nucleobase transport, it appears likely that a novel transport function is expressed in mutant cells. Moreover, we have recently inserted the JPA2 mutation into nucleoside transport-deficient S49 cells (4, 4a) without restoring the nucleoside transport capacity, suggesting that the augmented nucleobase transport capacity of JPA2 cells can be distinguished genetically from the nucleoside transport system (unpublished data). This novel transport function could be derived from the activation of a gene coding for a purine base carrier that is not expressed in parental cells. Alternatively, a preexisting expressed function present in wild-type S49 cells could be genetically altered to effect a change in its substrate specificity, such that it recognizes purine nucleobases with relatively high affinity in JPA2 cells. Finally, a mutation in the molecular architecture of the cell membrane or in a modifying or processing function for membrane permeases could account for the nucleobase transport phenotype of JPA2 cells. These alternatives remain to be distinguished.
